There is a possibility of Indian cos becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).
from Moneycontrol Business News https://ift.tt/3d7yWsO
In this website you will get all the news regarding about market of various countries and what to be the next prediction or status of market.
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
By BY BEN HUBBARD AND AURELIEN BREEDEN from NYT World https://ift.tt/3oyLkdW >
-
By STEPHANIE SAUL from NYT U.S. https://nyti.ms/2WdcYAk >
No comments:
Post a Comment